Skip to main content
. 2025 Aug 25;15(17):2139. doi: 10.3390/diagnostics15172139
mBC Metastatic breast cancer
HR+ Hormone receptor-positive
HER2− Human epidermal growth factor receptor 2-negative
PET Positron emission tomography
18F-FES 16α-18F-fluoro-17β-fluoroestradiol
FDA Food and Drug Administration
CDK4/6i Cyclin-dependent kinase 4/6 inhibitors
CT Computed tomography
ET Endocrine therapy
SUV Standardized uptake value